相关实验视频

Updated: Jun 27, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

与PWS自然史研究的PATH相比,接受二氧化胆延长释放片的普拉德-威利综合征患者的行为变化

Theresa V Strong¹, Jennifer L Miller², Shawn E McCandless³

¹Foundation for Prader-Willi Research, Covina, CA, 91723, USA. theresa.strong@fpwr.org.

Journal of neurodevelopmental disorders

|April 26, 2024

概括

与自然疾病进展相比,氧化胆延长释放 (DCCR) 在普拉德-威利综合征 (PWS) 患者中显著改善了过和行为症状. 这些发现表明,DCCR可能会减少PWS对患者和家人的整体负担.

科学领域:

神经行为代谢障碍神经行为代谢障碍
染色体15q11-q13区域疾病的遗传学
对罕见疾病的药理干预措施.

背景情况:

普拉德-威利综合征 (PWS) 是一种罕见的遗传性疾病,其特点是低血压,认知和行为问题,内分泌病变和过导致肥胖.
PWS是由15q11-q13.染色体上缺少父亲表达的基因引起的.
氧化胆延长释放 (DCCR) 已被研究其在治疗PWS过和相关行为并发症方面的有效性.

研究的目的:

评估DCCR对PWS患者的过和行为症状的长期影响.
为了比较DCCR在接受治疗的队列 (C601/C602研究) 与自然史队列 (PWS的PATH) 的疗效.

主要方法:

来自PWS自然历史研究的PATH队列与来自DCCR研究的参与者进行了比较 (C601/C602).
使用临床试验的超问卷 (HQ-CT) 评估了超.
使用普拉德-威利综合征概况 (PWSP) 问卷评估行为变化.

主要成果:

与自然史队列相比,DCCR治疗的参与者在26周和52周的HQ-CT得分显著改善.
即使在最糟糕的情景敏感性分析中,高吞度得分的改善也是一致的.
与自然史组相比,在DCCR治疗组中观察到PWSP的所有领域的显著改善.

结论:

长期使用DCCR会导致PWS患者的行为变化,与PWS综合征的自然过程有所不同.
在PWS患者中,DCCR治疗在减少多和其他行为问题方面表现出有效性.
DCCR有可能减轻PWS对患者,护理人员和家庭的负担.

关键词:

DCCRR是指DCCR是指DCCR是指DCCR是指DCCR的意思.过的情况过的情况自然历史自然历史的历史.普拉德 - 威利综合征是什么

更多相关视频

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...